Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial

PURPOSE: To determine if the change in tumor apparent diffusion coefficient (ADC) at diffusion-weighted (DW) MRI is predictive of pathologic complete response (pCR) to neoadjuvant chemotherapy for breast cancer. MATERIALS AND METHODS: In this prospective multicenter study, 272 consecutive women with...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Radiology
Autori principali: Partridge, Savannah C., Zhang, Zheng, Newitt, David C., Gibbs, Jessica E., Chenevert, Thomas L., Rosen, Mark A., Bolan, Patrick J., Marques, Helga S., Romanoff, Justin, Cimino, Lisa, Joe, Bonnie N., Umphrey, Heidi R., Ojeda-Fournier, Haydee, Dogan, Basak, Oh, Karen, Abe, Hiroyuki, Drukteinis, Jennifer S., Esserman, Laura J., Hylton, Nola M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Radiological Society of North America 2018
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6283325/
https://ncbi.nlm.nih.gov/pubmed/30179110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1148/radiol.2018180273
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi